The founder and CEO of medical device company Stimwave LLC lost her bid to undo convictions for health-care fraud and conspiracy after a federal appeals court found that the only errors at her two-week trial were harmless.
Although the district court wrongly barred certain defense witnesses from testifying, other evidence of Laura Perryman’s fraudulent intent was “overwhelming,” the US Court of Appeals for the Second Circuit said Monday.
Perryman was convicted of misrepresenting a plastic accessory for the StimQ PNS System—a neurotransmitting device for pain management—as a receiver in order to ensure doctors could bill payers like Medicare enough to ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.